Plans Would Cover Allergy and Asthma Care

Summary#

H.R. 11024 would amend title XXVII of the Public Health Service Act. It would require group health plans and health insurers offering group or individual coverage to cover allergy and asthma diagnostic testing and allergen immunotherapy. Its stated goal is to require coverage for these services; the bill is not law.

  • The proposed coverage duty applies to group health plans and insurers offering group or individual health insurance.
  • The required services named in the title are allergy and asthma diagnostic testing and allergen immunotherapy.
  • The supplied material does not include a short title or the bill text, so the exact wording and changes to current law cannot be checked. The bill has been referred to a House committee.

What it means for you#

  • People with group or individual health insurance: If enacted, the bill would require coverage of the named services. The title does not say whether you would still pay deductibles, copayments, or other charges.
  • Health plans and insurers: They would have to provide the required coverage if the bill becomes law. The available material does not explain how the requirement would be applied.

Money#

No cost information is in the available material.

  • No estimate is provided for public spending, plan or insurer costs, or effects on premiums or patients’ out-of-pocket costs.

What is unclear#

  • The full bill text and the current text of title XXVII were not supplied, so it is not possible to verify what would change from current law.
  • The material does not define which tests count as allergy or asthma diagnostic testing, or what services are included in allergen immunotherapy.
  • It does not say whether cost-sharing, medical-necessity rules, or other coverage limits would apply.
  • No start date, enforcement process, or details about how plans and insurers would meet the requirement are provided.
  • No publicly available information.

Case for#

  • A possible argument for the bill is that requiring coverage could help people with group or individual insurance obtain the named tests and treatment through their plans.
  • A coverage requirement could make plans’ obligations clearer, though the supplied material does not show how much coverage currently exists or how access might change.

Case against#

  • One concern is that the bill’s title does not specify what tests and treatments must be covered or what limits may apply, leaving patients and insurers uncertain.
  • It is unclear what costs the requirement could add for plans, insurers, or patients, and the available material gives no estimate.
  • Without the full text and current law, it is not possible to tell whether the proposal adds a new coverage duty or changes an existing one.